Decoy Therapeutics Inc. Deferred Revenue
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2026-08-12
- 2026-06-30: Deferred Revenue $3.00M.
- 2026-03-31: Deferred Revenue $3.23M.
- 2025-12-31: Deferred Revenue $3.23M.
- 2024-12-31: Deferred Revenue $0.00.
| Period end | Deferred Revenue |
|---|---|
| 2026-06-30 | $3.00M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $3.23M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $3.23M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 |